Clear Point Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$658K Sell
2,691
-14
-0.5% -$3.26K 0.51% 42
2025
Q4
$560K Sell
2,705
-7
-0.3% -$1.38K 0.43% 69
2025
Q3
$503K Sell
2,712
-1
-0% -$171 0.39% 78
2025
Q2
$414K Buy
2,713
+2
+0.1% +$307 0.35% 76
2025
Q1
$450K Buy
2,711
+23
+0.9% +$3.6K 0.4% 71
2024
Q4
$389K Buy
2,688
+3
+0.1% +$465 0.33% 76
2024
Q3
$435K Buy
2,685
+1
+0% +$159 0.34% 72
2024
Q2
$392K Buy
2,684
+3
+0.1% +$446 0.32% 73
2024
Q1
$424K Sell
2,681
-4
-0.1% -$637 0.35% 72
2023
Q4
$421K Buy
+2,685
New +$412K 0.37% 69

Other funds holding JNJ

Clear Point Advisors's JNJ Position: Q1 2026 in Review

Clear Point Advisors reduced its Johnson & Johnson (JNJ) stake by 0.52% in Q1 2026, selling an estimated $3.26K and leaving 2,691 shares worth $658K. The position accounts for 0.51% of the portfolio, ranked #42.

Clear Point Advisors first reported a position in JNJ in Q4 2023 and has held it in 10 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Clear Point Advisors held 2,691 shares of Johnson & Johnson worth $658K as of Q1 2026.
  • Clear Point Advisors sold 14 Johnson & Johnson shares in Q1 2026, an estimated $3.26K.
  • Johnson & Johnson made up 0.51% of Clear Point Advisors's portfolio in Q1 2026, its #42 holding.
  • Clear Point Advisors first reported a position in Johnson & Johnson in Q4 2023 and has held it in 10 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Clear Point Advisors's 13F filing for Q1 2026, filed 29 Apr 2026.